In addition, we aimed to investigate the effects of aberrant HCFC1 expression on biological behavior in patients with HCC with concomitant efforts to elucidate the possible mechanism beneath the same, providing important clues for the potential of HCFC1 as a therapeutic target in HCC. The gene discussed is HCFC1; the disease is hepatocellular carcinoma.